Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Press Conference with Trump and Leading Doctor

<< Previous

Bullboard Posts

Next >>

Comment by Nomoreshells4meon Mar 18, 2020 2:05pm

72 Views

Post# 30822560

RE:Press Conference with Trump and Leading Doctor

You heard that right, slumdawg. They are not omitting any possibilities. This isn't LBL's first rodeo. They've seen $77 before. Muscle has memory. Once the trial comes back successful then the pundits will hit the circuit to get the message out. It's kn everyone's best interest to move the share price into the $$$

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?